Table 3. Comparison between psoriasis and control groups according to AHR and CYP1A1 expression.
Variable | Psoriasis group (n=24) | Control group (n=10) | p-value |
---|---|---|---|
AHR expression | |||
Intensity | <0.001* | ||
None | 0 (0) | 7 (70.0) | |
Mild | 3 (12.5) | 3 (30.0) | |
Moderate | 9 (37.5) | 0 (0) | |
Strong | 12 (50.0) | 0 (0) | |
Distribution | <0.001* | ||
Negative | 0 (0) | 7 (70.0) | |
Basal | 1 (4.2) | 0 (0) | |
Both basal and suprabasal | 21 (87.5) | 3 (30.0) | |
Full thickness | 2 (8.3) | 0 (0) | |
CYP1A1 expression | |||
Intensity | <0.001* | ||
None | 0 (0) | 6 (60.0) | |
Mild | 0 (0) | 4 (40.0) | |
Moderate | 7 (29.2) | 0 (0) | |
Strong | 17 (70.8) | 0 (0) | |
Distribution | <0.001* | ||
Negative | 0 (0) | 6 (60.0) | |
Basal | 0 (0) | 0 (0) | |
Both basal and suprabasal | 17 (70.8) | 4 (40.0) | |
Full thickness | 7 (29.2) | 0 (0) |
Values are presented as number (%). AHR: aryl hydrocarbon receptor. *p<0.05.